Drug Designing and Biomarkers

A biomarker is an attribute which will be studied as an indicator of pathogenic and biological operation along side pharmacological retort to a therapeutic involvement. They indicate either normal or diseased activity within the body. Biomarkers are specific molecules, genes, gene products, hormones, cells or enzymes.

Drug designing is an ingenious process to seek out new medication centred on the knowledge of biological target. Drug is most ordinarily a little molecule that inhibits or activates the function of a biomolecule, which successively outcomes during a therapeutic benefit to the patient. Drug design commonly but not essentially relies on computational techniques. this sort of modelling is usually mentioned to as computer-aided drug design.

  • Drug targets
  • Ligand-based design
  • Structure-based design
  • Computer-aided drug design
  • Scoring functions

Related Conference of Drug Designing and Biomarkers

June 08-08, 2022

15th World Conference on Human Genomics and Genomic Medicine

Singapore City, Singapore
June 08-08, 2022

9th World Congress on Human Genetics and Genetic Diseases

Singapore City, Singapore
June 23-23, 2022

9th World Congress on Epigenetics and Chromosome

Barcelona, Spain
July 11-12, 2022

26th Global Congress on Biotechnology

Vienna, Austria
August 25-25, 2022

7th International Conference on Molecular Medicine and Diagnostics

Singapore City, Singapore
September 19-20, 2022

International Summit on Genomics and Proteomics

Dublin, Ireland
September 19-20, 2022

15th World Congress on Stem Cell Research

Dublin, Ireland
October 17-18, 2022

21st International Conference on Structural Biology

Barcelona, Spain
November 21-22, 2022

4th Annual summit on Cell Signaling and Cancer Therapy

Montreal, Canada

Drug Designing and Biomarkers Conference Speakers

Recommended Sessions

Related Journals

Are you interested in